Arming oncolytic adenoviruses with bi-specific T-cell engagers to improve antitumor efficacy 

Fajardo Calderón, Carlos Alberto (Data de defensa: 2017-05-19)

Oncolytic adenoviruses that selectively replicate in cancer cells while sparing normal tissue have gained considerable attention as novel anticancer drugs. However, clinical trials with these viruses have identified the ...